PharmEasy

PharmEasy – India’s Leading e-Pharmacy Platform!

API Holdings Limited (PharmEasy) is India’s leading Healthcare Delivery Platform with around 60% market share. PharmEasy has achieved total revenues of INR 2,361 Crs in FY 2021. PharmEasy has served over 5 million clients in 22,000+ pin codes through its 80,000+ partners spread across the country.

Please find below the Highlights of PharmEasy.

Company in brief:

• PharmEasy is a healthcare delivery platform. It helps patients to connect with local pharmacy stores and diagnostic centers enabling them to order medicines, healthcare products, and diagnostic tests.
• It had a revenue of more than $87.75 million in FY20 and currently enjoys over 60% market share. Recent Acquisitions by API Holdings Limited:
• API Holding Limited, acquired Medlife – a strong player in E-pharmacy sector in May 2021 and the resultant entity became the leading e-pharmacy in the country with serving 2+ million customers.
• API Holding Limited, signed agreement to acquire a 66.1% stake in Thyrocare for INR 4,546 Cr in June 2021. This was a First-ever acquisition of a listed company by an Indian unicorn.
• The Company also acquired Aknamed – India’s largest cloud based platform for hospital supply chin management, for about $180-$190 in September 2021.